FDA Approves First New ALS Drug in More Than 2 Decades

FDA Approves First New ALS Drug in More Than 2 Decades
Detail of a disabled man trying to getting on a ramp

The FDA has approved the first new drug to treat amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, in more than 20 years.

In clinical trials, the drug, Radicava (edaravone), reduced the rate of functional decline by one-third better than placebo. Before the approval, the only other drug approved to treat ALS was riluzole.

For treatment, a patient begins with daily dosing of Radicava for 14 days, followed by 2 weeks drug free. Subsequent treatment consists of receiving infusion on 10 of 14 days, followed by 14 days drug free.

The most common adverse events reported with Radicava, which is given via intravenous infusion, were bruising and abnormal walking. However, there are also other serious risks associated with the drug, such as hives, swelling, shortness of breath, and allergic reaction to an ingredient in the medication.

The medication should become available in August.

DISCLAIMER: MedShadow provides information and resources related to medications, their effects, and potential side effects. However, it is important to note that we are not a substitute for professional medical advice, diagnosis, or treatment. The content on our site is intended for educational and informational purposes only. Individuals dealing with medical conditions or symptoms should seek guidance from a licensed healthcare professional, such as a physician or pharmacist, who can provide personalized medical advice tailored to their specific circumstances.

While we strive to ensure the accuracy and reliability of the information presented on MedShadow, we cannot guarantee its completeness or suitability for any particular individual's medical needs. Therefore, we strongly encourage users to consult with qualified healthcare professionals regarding any health-related concerns or decisions. By accessing and using MedShadow, you acknowledge and agree that the information provided on the site is not a substitute for professional medical advice and that you should always consult with a qualified healthcare provider for any medical concerns.

Recommend More Articles Like This?

Show Comments (0)
0 0 votes
Article Rating
Notify of
Inline Feedbacks
View all comments
Would love your thoughts, please comment.x